Peregrine uses the term "initiate" whenever they PR the start of the trial. So when they put that in a News Release with a date, one has to assume "initiate" = START.
Peregrine Pharmaceuticals Initiates Sunrise Pivotal Phase III Clinical Trial of Bavituximab in Second
News 
Market Data 
Discover 
